Cargando…

Formulating Poorly Water Soluble Drugs

A pharmaceutical scientist's approach toward solubility enhancement of a poorly water-soluble molecule typically includes detailed characterization of the compound's physiochemical properties, solid-state modifications, advanced formulation design, non-conventional process technologies, ad...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Williams III, Robert O. (Editor ), Watts, Alan B. (Editor ), Miller, Dave A. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York, NY : Springer New York : Imprint: Springer, 2012.
Edición:1st ed. 2012.
Colección:AAPS Advances in the Pharmaceutical Sciences Series, 3
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-1-4614-1144-4
003 DE-He213
005 20220115021911.0
007 cr nn 008mamaa
008 111202s2012 xxu| s |||| 0|eng d
020 |a 9781461411444  |9 978-1-4614-1144-4 
024 7 |a 10.1007/978-1-4614-1144-4  |2 doi 
050 4 |a RS400-431 
072 7 |a PSB  |2 bicssc 
072 7 |a MED072000  |2 bisacsh 
072 7 |a PNB  |2 thema 
082 0 4 |a 615.19  |2 23 
245 1 0 |a Formulating Poorly Water Soluble Drugs  |h [electronic resource] /  |c edited by Robert O. Williams III, Alan B. Watts, Dave A. Miller. 
250 |a 1st ed. 2012. 
264 1 |a New York, NY :  |b Springer New York :  |b Imprint: Springer,  |c 2012. 
300 |a XII, 648 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a AAPS Advances in the Pharmaceutical Sciences Series,  |x 2210-738X ;  |v 3 
505 0 |a Route-Specific Challenges in Delivery of Poorly Water Soluble Drugs -- Optimizing the Formulation of Poorly Water Soluble Drugs -- Solid-State Techniques for Improving Solubility -- Mechanical Particle Size Reduction Techniques -- Solubilized Formulations -- Injectable Formulations of Poorly Water Soluble Drugs -- Design and Development of Self-Emulsifying Lipid Formulations for Improving Oral Bioavailability of Poorly Water-Soluble and Lipophilic Drugs -- Structured Development Approach for Amorphous Systems -- Melt Extrusion -- Spray Drying Technology -- Pharmaceutical Cryogenic Technologies -- Precipitation Technologies for Nanoparticle Production -- Emerging Technologies to Increase the Bioavailability of Poorly Water Soluble Drugs -- Regulatory Considerations for Development and Commercialization of Poorly Water Soluble Drugs. 
520 |a A pharmaceutical scientist's approach toward solubility enhancement of a poorly water-soluble molecule typically includes detailed characterization of the compound's physiochemical properties, solid-state modifications, advanced formulation design, non-conventional process technologies, advanced analytical characterization, and specialized product performance analysis techniques. The scientist must also be aware of the unique regulatory considerations pertaining to the non-conventional approaches often utilized for poorly water-soluble drugs. One faced with the challenge of developing a drug product from a poorly soluble compound must possess at minimum a working knowledge of each of the abovementioned facets and detailed knowledge of most. In light of the magnitude of the growing solubility problem to drug development, this is a significant burden especially when considering that knowledge in most of these areas is relatively new and continues to develop. There are numerous literature resources available to pharmaceutical scientists to educate and provide guidance toward formulations development with poorly water-soluble drugs; however, a single, comprehensive reference is lacking. Furthermore, without access to a vast journal library, the detailed methods used to implement these approaches are not available. The objective of this volume is therefore to consolidate within a single text the most current knowledge, practical methods, and regulatory considerations pertaining to formulations development with poorly water-soluble molecules. 
650 0 |a Pharmaceutical chemistry. 
650 1 4 |a Pharmaceutics. 
700 1 |a Williams III, Robert O.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Watts, Alan B.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Miller, Dave A.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9781461411437 
776 0 8 |i Printed edition:  |z 9781489985927 
776 0 8 |i Printed edition:  |z 9781461411451 
830 0 |a AAPS Advances in the Pharmaceutical Sciences Series,  |x 2210-738X ;  |v 3 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-1-4614-1144-4  |z Texto Completo 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)